It has been confirmed by a study that downregulated FDFT1 is related to late tumor progression and worse prognosis in CRC, and FDFT1 suppresses the tumorigenesis through negative regulation of AKT/mTOR/HIF1α signaling pathway (Weng et al., 2020). Here, FDFT1 is linked to neoplasm.